VJHemOnc Podcast Comparing the ICC and WHO classifications for MDS and their impact on clinical practice
Mar 24, 2023
Experts Amer Zeidan and Sanam Loghavi discuss the updated ICC and WHO classifications for MDS. They explore the overlap and differences between the two systems and highlight the challenges in classifying MDS. The podcast also emphasizes the importance of a comprehensive report and the potential of AI in generating such reports. The significance of a uniform classification for MDS and its impact on clinical practice is highlighted, along with the need for improved treatments. Lastly, the podcast emphasizes the importance of providing accurate patient education resources and recognizing genetic abnormalities morphologically.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
Evolution of MDS and AML classifications and their clinical impact
02:10 • 3min
Classification of Myelodysplastic Syndromes (MDS)
05:03 • 20min
Challenges in Classifying Myelodysplastic Syndromes (MDS)
25:00 • 11min
The Importance of a Comprehensive Report and the Potential of AI
35:54 • 2min
Uniform Classification and Impact on Clinical Practice
37:57 • 3min
The Importance of Updated Patient Education Resources
41:12 • 3min